Skip to content
1.1-What-We-Do.jpg

What We Do

ADMA Biologics is an end-to-end biopharmaceutical company leading the way as a producer of plasma-derived therapeutics

Learn more below about our immune globulin product portfolio, our patented technology, our optimized manufacturing process, and contract development and manufacturing organization (CDMO) capabilities
FDA-Approved Immue Globulin Product Portfolio, Optimized Manufacturing Process & CDMO Capabilities, Established Plasma Collection Network, and Proven and Patented Immunotechnology

ADMA Biologics is an end-to-end biopharmaceutical company leading the way as a producer of plasma-derived therapeutics.

Learn more below about our immune globulin product portfolio, our patented technology, our optimized manufacturing process, and CDMO capabilities
infographic
Graphic showing vials containing antibodies

Our products

Explore our FDA-approved immune globulin product portfolio.

Icon representing contract manufacturing

Contract manufacturing

We offer a full suite of CDMO and contract manufacturing organization (CMO) opportunities. Partner with us for your clinical-stage or commercial aseptic filling, packaging requirements, and our unique good manufacturing practice (GMP) testing.

Graphic of Antibodies

Our patented immunotechnology

Discover our proven immunotechnology that has forged a new path forward in improving the lives of the immune compromised and other patients at risk for infection.

Graphic of molecule

Manufacturing process

We have created a robust, sustainable, and controlled manufacturing process for producing our commercially available plasma-derived products.

ADMA BioCenters is an organization specializing in the collection of human plasma used to make special medications for the treatment and prevention of diseases.